about
Colorectal cancer: epigenetic alterations and their clinical implications.DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy.Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
MicroRNA Methylation in Colorectal Cancer.
@ast
MicroRNA Methylation in Colorectal Cancer.
@en
MicroRNA Methylation in Colorectal Cancer.
@nl
type
label
MicroRNA Methylation in Colorectal Cancer.
@ast
MicroRNA Methylation in Colorectal Cancer.
@en
MicroRNA Methylation in Colorectal Cancer.
@nl
prefLabel
MicroRNA Methylation in Colorectal Cancer.
@ast
MicroRNA Methylation in Colorectal Cancer.
@en
MicroRNA Methylation in Colorectal Cancer.
@nl
P2860
P1476
MicroRNA Methylation in Colorectal Cancer.
@en
P2093
Johanna E Lotsari-Salomaa
Sippy Kaur
P2860
P304
P356
10.1007/978-3-319-42059-2_6
P407
P577
2016-01-01T00:00:00Z